My take on the biotech industry from a discussion with @AGatlin_IBD at @IBDinvestors.
“The biotech industry continues to deliver unmatched innovation for patients. The industry, frankly, is crushing it on the innovation side." https://t.co/C6BBc3GVjy
How to better understand the utter complexities of our immune system by deep mining of the biomedical literature corpus https://t.co/o5zecahpGD @NatureBiotech By @TechnionLive's @KsenyaKveler@shenorr and colleagues
Your morning's ImmuneExpresso :-)
Does genome sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness @ZornitzaS @MelbGenomics https://t.co/Yx4aaSmEAm